Skip to main content
Premium Trial:

Request an Annual Quote

'Social' Science

Martin Fenner from Germany's Hannover Medical School Cancer Center tells the Raleigh, NC-based News & Observer about his efforts to make science more social. The main issue, Fenner says, is that scientists have few incentives for that kind of work. "Researchers are valued by their publications and grants, and other contributions to science — producing research data, communicating science, teaching, et cetera — usually fall under the table," he says. Fenner is working on two initiatives, Open Researcher and Contributor ID, or ORCID, and Altmetrics, both of which aim to change that. ORCID assigns researchers a number to make identifying their research contributions easier, while Altmetrics measures the impact of blog posts, tweets, and more. "A more networked science makes a lot of sense for science as a whole, but at least initially, offers little extra value to the individual researcher," Fenner says. "This makes change difficult."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.